Robert S. Coffin

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio et al. · Journal of Clinical Oncology · 2015 · 2.6K citations · Full text

Medicine, Immunology, Oncology +17

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

Neil Senzer, Howard L. Kaufman, Thomas Amatruda et al. · Journal of Clinical Oncology · 2009 · 615 citations · Full text

Medicine, Clinical Sciences, Oncology +17

A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

Jennifer Hu, Robert S. Coffin, C. J. Davis et al. · Clinical Cancer Research · 2006 · 568 citations

Medicine, Oncology, Pharmacotherapy +16

Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck

Kevin J. Harrington, Mohan Hingorani, Mary Anne Tanay et al. · Clinical Cancer Research · 2010 · 260 citations

Medicine, Oncology, Radiation Oncology +17

Protection of Neuronal Cells from Apoptosis by Hsp27 Delivered with a Herpes Simplex Virus-based Vector

Marcus Wagstaff, Yollanda Collaço-Moraes, Jill Smith et al. · Journal of Biological Chemistry · 1999 · 213 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17